Genmab A/S
GNMSF
$241.84
-$3.16-1.29%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.27B | 1.13B | 1.13B | 683.04M | 803.76M |
| Total Depreciation and Amortization | 64.94M | 62.94M | 59.94M | 51.88M | 47.79M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -196.63M | 90.37M | 42.37M | 349.13M | 168.54M |
| Change in Net Operating Assets | -99.21M | -94.21M | -108.21M | -105.10M | -43.22M |
| Cash from Operations | 1.04B | 1.19B | 1.13B | 978.95M | 976.86M |
| Capital Expenditure | -41.03M | -35.03M | -27.03M | -23.27M | -31.98M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | -1.78B | -1.78B | -1.78B | -1.78B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 68.76M | 549.76M | 374.76M | 295.47M | 418.38M |
| Cash from Investing | 27.73M | -1.27B | -1.44B | -1.51B | -1.40B |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -23.00M | -22.00M | -23.00M | -48.00M | -47.00M |
| Issuance of Common Stock | 61.00M | 57.00M | 65.00M | 63.00M | 60.00M |
| Repurchase of Common Stock | -730.00M | -761.00M | -840.00M | -838.00M | -540.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -459.24M | -493.24M | -565.24M | -568.85M | -525.26M |
| Foreign Exchange rate Adjustments | 110.18M | 101.18M | 92.18M | -99.22M | -54.86M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 714.82M | -467.18M | -783.18M | -1.20B | -999.86M |